Biotech Funding Trends: Insights from Entrepreneurs and Investors

Based on interviews with dedicated biotech entrepreneurs and high–level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations.
The book outlines the various funding opportunities for the biotech industry in Europe and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment. A must–have for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry.

Spis treści:
Preface.
Acknowledgments.
Limit of Liability/Disclaimer of Warranty.
Executive Summary.
1. Introduction.
1.1 Development of the Private Equity and Venture Capital Market.
1.2 Development of the Biotech Industry.
2. Methodology.
2.1 Formulating the Research Goal.
2.2 Conducting the Study.
2.3 Evaluating the Results.
3. Data Analysis and Interpretation of Results.
3.1 Description of Interview Partners.
3.2 Major Characteristics of an Entrepreneur.
3.3 Major Characteristics of a Venture Capitalist.
3.4 The Most Important Partnering Criteria.
3.5 Financing Models.
3.6 Biotech Research Areas.
3.7 Alliances and Funding in the Early Stage.
3.8 Alliances and Funding in the Late Stage.
3.9 Exit Routes.
3.10 Primary Causes of Failure.
3.11 Best–practice Countries for Funding Biotech Start–ups.
3.12 Most Striking Differences between the US and European Venture Capital Markets.
4. Biotech Case Studies.
4.1 AUSTRIANOVA Biomanufacturing AG.
4.2 AVIR Green Hills Biotechnology AG.
4.3 EUCODIS GmbH
4.4 Intercell AG.
4.5 onepharm Research & Development GmbH.
5. Summary and Conclusions.
5.1 The Challenge: When Science Meets B usiness.
5.2 Checklists.
5.3 Final Observations.
6. Outlook and Recommendations.
Epilogue.
References.
Appendix A: List of Abbreviations.
Appendix B: Glossary.
Appendix C.
Appendix D: Questionnaires.
Index.

Nota biograficzna:
Alexandra Carina Gruber, born in 1971 in Vienna, Austria, graduated in pharmacy from the University in Vienna in 1997 and has been working in the pharmaceutical industry for the past 12 years, where she has held various marketing and business development positions and developed a profound expertise in the marketing and licensing of biotech and generic products. During her professional career she committed herself to an Executive MBA study course from the University of Business Administration and Economics in Vienna together with the University of Minnesota as well as a postgraduate education in Finance at the Danube University Krems together with the University of British Columbia, Vancouver. For more information, please go to www.acgruber.eu

Okładka tylna:
Based on interviews with dedicated biotech entrepreneurs and high–level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations.
The book outlines the various funding opportunities for the biotech industry in Europe and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment. A must–have for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry.